Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gena, Kanas"'
Autor:
Laura Durbin, Bhavna Murali, Song Li, Linda Zhao, Stephanie Hawthorne, Gena Kanas, Christine Davis, Otávio Clark
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100462- (2021)
Purpose: To report the treatment patterns of non-small-cell lung cancer (NSCLC) patients in China based on a survey of physicians (CancerMPact). Methods: 117 Chinese physicians from 27 cities in mainland China were recruited for an online survey in O
Externí odkaz:
https://doaj.org/article/5115001ce128404c85f731108ddffec7
Publikováno v:
Leukemia & Lymphoma. 63:54-63
Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) treatments have been rapidly evolving for patients treated in later lines of therapy (LoT). Country-specific cancer registry data for the US and Western Europe (WE) were combined with
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:EPR21-034
Publikováno v:
Future Oncology. 17:921-930
Aim: To report the results of a patient epidemiology model for multiple myeloma (MM) treatment by line of therapy (LOT) in the USA. Materials & methods: Surveillance, Epidemiology and End Results registry data and physician surveys were combined to p
Autor:
David Robinson, Christine Davis, Matthew Turnure, Stephanie Hawthorne, Otavio Clark, Gena Kanas, Madelyn Hanson, Linda Zhao
Publikováno v:
Cancer Management and Research. 12:5633-5639
Context Melanoma treatment has substantially changed over the last several years, yet little information regarding physician's preferences around treatment exists. Objective Our aim is to describe the results of the CancerMPact (CMP) survey performed
Autor:
David Robinson, Stephanie Hawthorne, Linda Zhao, Otavio Clark, Gena Kanas, Christine Davis, Madelyn Hanson
Publikováno v:
Future Oncology. 16:255-262
Aim: To report the results of a survey of USA physicians (CancerMPact) that treat non-small-cell lung cancer patients. Materials & methods: 60 physicians were surveyed. Questions covered aspects of the treatment for all stages of the disease. Results
Autor:
Bhavna Murali, Laura Durbin, Sapna Vijaykumar, Linda Yang, Song Li, Linda Zhao, Stephanie Hawthorne, Gena Kanas, Christine Davis, Otávio Clark
Publikováno v:
Breast cancer research and treatment. 195(3)
Purpose To report the treatment utilization patterns for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer in urban mainland China (CancerMPact®). Methods The results presented are from an onli
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2010, Iss default, Pp 1-14 (2010)
Gena Kanas1, Libby Morimoto1, Fionna Mowat1, Cynthia O’Malley2, Jon Fryzek3, Robert Nordyke21Exponent, Inc., Menlo Park, CA, USA; 2Amgen, Inc., Thousand Oaks, CA, USA; 3MedImmune, Gaithersburg, MD, USAAbstract: Oncology outcomes research could bene
Externí odkaz:
https://doaj.org/article/e1d283b7ecc14949857aed8cfc8793e3
Autor:
Eloisa, de Sá Moreira, David, Robinson, Stephanie, Hawthorne, Linda, Zhao, Madelyn, Hanson, Gena, Kanas, Matthew, Turnure, Christine, Davis, Otavio, Clark
Publikováno v:
Cancer Management and Research
Purpose We describe patterns of care and treatment outcomes for non-metastatic PCa (nmPCA), either hormone-sensitive or castration-resistant, in the United States of America (USA) in 2018. Methods A survey (CancerMPact®) recruited physicians nationw
Publikováno v:
Blood. 136:2-3
Introduction: Treatment for multiple myeloma (MM) has evolved over time, leading to improved survival outcomes for patients. However, information on real world clinical practice, such as the proportion of patients receiving each treatment regimen or